【Scinopharm】February 2026 Revenue Reaches NT$207 Million (YoY +26.3%)
Scinopharm (1789) announced its February 2026 monthly revenue of NT$207 million, a significant year-… · 2026-02-01
Scinopharm (1789) announced its February 2026 monthly revenue of NT$207 million, a significant year-… · 2026-02-01
ScinoPharm announced the board's resolution for cash dividend distribution. Shareholders will receiv… · 2026-05-27
ScinoPharm Taiwan (TWSE: 1789), operating in the biotech and medical industry, announced its monthly… · 2026-05-01
ScinoPharm announced that the 116th AGM approved the removal of non-compete restrictions for its dir… · 2026-05-27
ScinoPharm has approved the lifting of non-compete restrictions for Chairman Luo Chih-hsien and Gene… · 2026-05-27
ScinoPharm held its Annual General Shareholders' Meeting on May 27, 115, approving a cash dividend o… · 2026-05-27
Shenlong announced its March 2026 monthly revenue of 325 million yuan, marking a 3.4% increase compa… · 2026-03-01
ScinoPharm has been invited to participate in an online investor conference hosted by Uni-President … · 2026-06-04
Shenlon's monthly revenue for April 2026 reached NT$255 million, a year-on-year increase of 12.5%. T… · 2026-04-01
ScinoPharm announced that its Board of Directors approved the consolidated financial report for the … · 2026-05-06
Unified Enterprise (股) Company has announced a change in its representative director. Zheng Jingyuan… · 2026-04-30
ScinoPharm announced that its board of directors is scheduled to convene on May 6, 2026, to delibera… · 2026-04-28
Shenlong announced its March 2026 monthly revenue of 325 million yuan, marking a 3.4% increase compa… · 2026-03-01
Scinopharm (1789) announced its February 2026 monthly revenue of NT$207 million, a significant year-… · 2026-02-01
Unified Enterprise (股) Company has announced a change in its representative director. Zheng Jingyuan… · 2026-04-30
ScinoPharm announced that its board of directors is scheduled to convene on May 6, 2026, to delibera… · 2026-04-28
Shenlon's monthly revenue for April 2026 reached NT$255 million, a year-on-year increase of 12.5%. T… · 2026-04-01
ScinoPharm announced that its Board of Directors approved the consolidated financial report for the … · 2026-05-06